{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:25:37Z","timestamp":1766157937192},"reference-count":37,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T00:00:00Z","timestamp":1452729600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0022215115003527_sec_a1\"><jats:title>Objective:<\/jats:title><jats:p>To verify the hypothesis that intravenous frusemide reduces endolymphatic hydrops, as evaluated by three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging following intratympanic gadolinium administration.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215115003527_sec_a2\"><jats:title>Methods:<\/jats:title><jats:p>The study comprised 12 patients (7 females and 5 males, aged 19\u201374 years) with M\u00e9ni\u00e8re's disease. Disease duration ranged from 0.5 to 8 years, with a frequency of 0.5 to 6 vertigo spells per month, as calculated in the last 6 months. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging was performed 24 hours after intratympanic injection of gadobutrol diluted eight-fold. Frusemide 20 mg was given intravenously immediately after imaging. Magnetic resonance imaging was repeated after 1 hour, using the same parameters and sequence.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215115003527_sec_a3\"><jats:title>Results:<\/jats:title><jats:p>All patients showed enhancement defects, indicating endolymphatic hydrops of variable degrees. No modifications occurred at the second magnetic resonance imaging performed 1 hour after frusemide administration.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215115003527_sec_a4\"><jats:title>Conclusion:<\/jats:title><jats:p>There was no evidence of endolymphatic hydrops modification 1 hour after intravenously administered frusemide. Therefore, loop diuretics in M\u00e9ni\u00e8re's disease, which are today used on an empirical basis, must be reconsidered. Implications of these outcomes are discussed and related to the role of endolymphatic hydrops in the development of M\u00e9ni\u00e8re's disease.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0022215115003527","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T15:09:28Z","timestamp":1452784168000},"page":"242-247","source":"Crossref","is-referenced-by-count":8,"title":["Does the intravenous administration of frusemide reduce endolymphatic hydrops?"],"prefix":"10.1017","volume":"130","author":[{"given":"F","family":"Fiorino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Mattellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Vento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Mazzocchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Bianconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F B","family":"Pizzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"key":"S0022215115003527_ref34","first-page":"115","volume-title":"M\u00e9ni\u00e8re's Disease","author":"Kimura","year":"1999"},{"key":"S0022215115003527_ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e31829e83df"},{"key":"S0022215115003527_ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e31820e7614"},{"key":"S0022215115003527_ref24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003599.pub2"},{"key":"S0022215115003527_ref10","doi-asserted-by":"publisher","DOI":"10.3109\/00016480802593513"},{"key":"S0022215115003527_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5955(83)90103-X"},{"key":"S0022215115003527_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(95)70308-X"},{"key":"S0022215115003527_ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2011.07.060"},{"key":"S0022215115003527_ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200501000-00013"},{"key":"S0022215115003527_ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e31802c300c"},{"key":"S0022215115003527_ref13","doi-asserted-by":"publisher","DOI":"10.3109\/00016489309128123"},{"key":"S0022215115003527_ref21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/000348949410300607","article-title":"Changes in immunostaining of cochleas with experimentally induced endolymphatic hydrops","volume":"103","author":"Ichimiya","year":"1994","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"S0022215115003527_ref1","doi-asserted-by":"publisher","DOI":"10.1177\/00034894800896S201"},{"key":"S0022215115003527_ref14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/00016489850154847","article-title":"The furosemide test and vestibular status in M\u00e9ni\u00e8re's disease","volume":"118","author":"Tsunoda","year":"1998","journal-title":"Acta Otolaryngol"},{"key":"S0022215115003527_ref31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00016489950181279","article-title":"M\u00e9ni\u00e8re's disease and endolymphatic hydrops without M\u00e9ni\u00e8re's symptoms: temporal bone histopathology","volume":"119","author":"Vasama","year":"1999","journal-title":"Acta Otolaryngol"},{"key":"S0022215115003527_ref12","doi-asserted-by":"publisher","DOI":"10.3109\/00016487509124706"},{"key":"S0022215115003527_ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-010-1353-5"},{"key":"S0022215115003527_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2013.10.015"},{"key":"S0022215115003527_ref2","first-page":"1","article-title":"Endolymphatic hydrops: an overview and classification","volume":"106","author":"Schuknecht","year":"1983","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"key":"S0022215115003527_ref3","doi-asserted-by":"publisher","DOI":"10.1177\/000348948709600418"},{"key":"S0022215115003527_ref6","doi-asserted-by":"publisher","DOI":"10.3109\/00016480903143986"},{"key":"S0022215115003527_ref11","doi-asserted-by":"publisher","DOI":"10.1080\/0036554021000028079"},{"key":"S0022215115003527_ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200303000-00025"},{"key":"S0022215115003527_ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e31802c751a"},{"key":"S0022215115003527_ref22","doi-asserted-by":"publisher","DOI":"10.3109\/00016489509121870"},{"key":"S0022215115003527_ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-010-1265-4"},{"key":"S0022215115003527_ref25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.34.5.910"},{"key":"S0022215115003527_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5955(80)90009-X"},{"key":"S0022215115003527_ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e318248ee1f"},{"key":"S0022215115003527_ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-012-2087-3"},{"key":"S0022215115003527_ref30","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/MAO.0b013e31825d9a95","article-title":"In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed M\u00e9ni\u00e8re's disease","volume":"33","author":"Gurkov","year":"2012","journal-title":"Otol Neurotol"},{"key":"S0022215115003527_ref32","doi-asserted-by":"publisher","DOI":"10.3109\/00016489.2013.795290"},{"key":"S0022215115003527_ref36","first-page":"1","article-title":"Autoregulation of cochlear blood flow","volume":"62","author":"Nakashima","year":"1999","journal-title":"Nagoya J Med Sci"},{"key":"S0022215115003527_ref4","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20723"},{"key":"S0022215115003527_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(95)70102-8"},{"key":"S0022215115003527_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2009.04.013"},{"key":"S0022215115003527_ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e31822a1ce2"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022215115003527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T16:38:10Z","timestamp":1654101490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022215115003527\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0022215115003527"],"URL":"https:\/\/doi.org\/10.1017\/s0022215115003527","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,14]]}}}